424 related articles for article (PubMed ID: 23443443)
1. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.
Johnson RH; Chien FL; Bleyer A
JAMA; 2013 Feb; 309(8):800-5. PubMed ID: 23443443
[TBL] [Abstract][Full Text] [Related]
2. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
3. Trends in breast cancer by race and ethnicity: update 2006.
Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
[TBL] [Abstract][Full Text] [Related]
4. Trends in breast cancer by race and ethnicity.
Ghafoor A; Jemal A; Ward E; Cokkinides V; Smith R; Thun M
CA Cancer J Clin; 2003; 53(6):342-55. PubMed ID: 15224974
[TBL] [Abstract][Full Text] [Related]
5. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
Li CI; Malone KE; Daling JR
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
[TBL] [Abstract][Full Text] [Related]
6. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
7. Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project.
Joslyn SA; Foote ML; Nasseri K; Coughlin SS; Howe HL
Breast Cancer Res Treat; 2005 Jul; 92(2):97-105. PubMed ID: 15986118
[TBL] [Abstract][Full Text] [Related]
8. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
Fields EC; DeWitt P; Fisher CM; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
[TBL] [Abstract][Full Text] [Related]
9. Trends in stage at diagnosis for young breast cancer patients in the United States.
DeSantis CE; Ma J; Jemal A
Breast Cancer Res Treat; 2019 Feb; 173(3):743-747. PubMed ID: 30426307
[TBL] [Abstract][Full Text] [Related]
10. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement.
Cronin-Fenton DP; Ries LA; Clegg LX; Edwards BK
J Natl Cancer Inst; 2007 Jul; 99(13):1044-9. PubMed ID: 17596573
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
[TBL] [Abstract][Full Text] [Related]
13. Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.
Davis Lynn BC; Chernyavskiy P; Gierach GL; Rosenberg PS
J Natl Cancer Inst; 2022 Feb; 114(2):263-270. PubMed ID: 34508608
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic disparities and breast cancer hormone receptor status.
Andaya AA; Enewold L; Horner MJ; Jatoi I; Shriver CD; Zhu K
Cancer Causes Control; 2012 Jun; 23(6):951-8. PubMed ID: 22527173
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
16. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and treatment for ductal carcinoma in situ of the breast.
Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
[TBL] [Abstract][Full Text] [Related]
18. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
19. Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status/race/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database.
Yan W; Christos P; Nori D; Chao KS; Ravi A
Am J Clin Oncol; 2013 Dec; 36(6):552-7. PubMed ID: 22868241
[TBL] [Abstract][Full Text] [Related]
20. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
